TABLE 2.
Results of the network meta-analysis of the clinical effectiveness rate (upper right quarter) and the performance status (lower left quarter).
| ADI + NP | 0.72 (0.57.0.89) | 0.72 (0.22.2.15) | 1.41 (0.94.2.12) | 1.057 (0.41.2.66) | 1.39 (0.66.3.089) | 1.46 (0.77.2.72) | 0.91 (0.62.1.33) | 1.075 (0.74.1.56) | 1.41 (1.00.1.99) | 0.87 (0.55.1.39) | 0.90 (0.51.1.58) | 1.33 (0.83.2.13) | 1.00 (0.65.1.55) | 1.13 (0.31.3.98) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.27 (0.19,0.38) | NP | 1.005 (0.31.2.94) | 1.95 (1.40,2.78) | 1.48 (0.58.3.59) | 1.93 (0.94.4.17) | 2.025 (1.11,3.68) | 1.26 (0.93.1.75) | 1.50 (1.091,2.07) | 1.95 (1.49,2.58) | 1.22 (0.82.1.80) | 1.25 (0.74.2.10) | 1.84 (1.23,2.76) | 1.39 (0.95.2.021) | 1.57 (0.44.5.48) |
| 0.51 (0.12.2.41) | 1.92 (0.48.8.59) | AI + NP | 1.93 (0.62.6.45) | 1.44 (0.36.6.22) | 1.93 (0.50.7.99) | 1.99 (0.58.7.099) | 1.24 (0.42.4.14) | 1.49 (0.48.5.045) | 1.94 (0.64.6.44) | 1.19 (0.39.4.20) | 1.25 (0.38.4.29) | 1.84 (0.57.6.13) | 1.39 (0.44.4.79) | 1.56 (0.31.8.99) |
| 0.79 (0.44.1.44) | 2.99 (1.87,4.82) | 1.57 (0.32.6.74) | CKSI + NP | 0.74 (0.29.1.98) | 0.99 (0.45.2.35) | 1.026 (0.52.2.076) | 0.65 (0.41.1.036) | 0.77 (0.47.1.23) | 1.00 (0.64.1.56) | 0.62 (0.37.1.052) | 0.64 (0.35.1.19) | 0.95 (0.55.1.58) | 0.71 (0.42.1.17) | 0.79 (0.21.3.20) |
| 0.84 (0.25.3.012) | 3.15 (0.9810.84) | 1.66 (0.25.10.1) | 1.056 (0.30.3.95) | CSI + NP | 1.31 (0.43.4.15) | 1.37 (0.47.4.28) | 0.86 (0.33.2.34) | 1.013 (0.39.2.75) | 1.32 (0.52.3.45) | 0.82 (0.31.2.33) | 0.85 (0.31.2.47) | 1.24 (0.48.3.46) | 0.94 (0.37.2.55) | 1.087 (0.21.4.83) |
| 0.69 (0.23.1.94) | 2.57 (0.97.6.93) | 1.35 (0.22.7.53) | 0.85 (0.29.2.63) | 0.81 (0.17.3.86) | DLSI + NP | 1.047 (0.37.2.71) | 0.66 (0.28.1.42) | 0.77 (0.34.1.66) | 1.015 (0.45.2.18) | 0.63 (0.27.1.44) | 0.65 (0.25.1.56) | 0.96 (0.39.2.18) | 0.72 (0.31.1.606) | 0.80 (0.19.3.60) |
| 0.72 (0.30.1.78) | 2.71 (1.21,6.28) | 1.41 (0.27.7.14) | 0.91 (0.35.2.40) | 0.86 (0.20.3.66) | 1.054 (0.30.3.75) | HCSI + NP | 0.63 (0.32.1.23) | 0.74 (0.38.1.45) | 0.96 (0.50.1.88) | 0.60 (0.30.1.22) | 0.62 (0.28.1.37) | 0.93 (0.45.1.86) | 0.70 (0.33.1.37) | 0.77 (0.20.3.24) |
| 2.026 (1.016,4.052) | 7.57 (4.25,13.79) | 3.97 (0.85.17.81) | 2.53 (1.17,5.55) | 2.40 (0.601.8.93) | 2.94 (0.94.8.94) | 2.80 (1.011,7.55) | JOEI + NP | 1.18 (0.75.1.89) | 1.54 (1.01,2.35) | 0.96 (0.57.1.59) | 0.99 (0.54.1.82) | 1.46 (0.88.2.40) | 1.098 (0.67.1.77) | 1.23 (0.34.4.63) |
| 0.75 (0.381.49) | 2.80 (1.59,5.084) | 1.46 (0.30.6.62) | 0.93 (0.44.2.01) | 0.89 (0.22.3.30) | 1.082 (0.35.3.31) | 1.034 (0.37.2.84) | 0.37 (0.16,0.84) | KAI + NP | 1.30 (0.87.1.98) | 0.82 (0.49.1.35) | 0.84 (0.45.1.52) | 1.23 (0.72.2.071) | 0.93 (0.57.1.51) | 1.048 (0.28.3.82) |
| 0.67 (0.40.1.14) | 2.54 (1.74,3.70) | 1.32 (0.28.5.44) | 0.85 (0.47.1.54) | 0.80 (0.22.2.72) | 0.98 (0.34.2.81) | 0.94 (0.37.2.26) | 0.34 (0.16,0.67) | 0.91 (0.44.1.79) | KLTI + NP | 0.62 (0.39.1.004) | 0.64 (0.35.1.16) | 0.94 (0.58.1.56) | 0.71 (0.44.1.14) | 0.81 (0.22.2.86) |
| 0.47 (0.21.1.048) | 1.75 (0.85.3.68) | 0.91 (0.18.4.45) | 0.59 (0.25.1.42) | 0.55 (0.13.2.22) | 0.69 (0.20.2.25) | 0.65 (0.21.1.94) | 0.23 (0.091,0.59) | 0.63 (0.25.1.58) | 0.69 (0.31.1.57) | SFI + NP | 1.036 (0.54.1.98) | 1.52 (0.86.2.68) | 1.14 (0.65.2.00) | 1.30 (0.34.5.45) |
| 0.64 (0.31.1.33) | 2.40 (1.27,4.61) | 1.25 (0.26.5.75) | 0.80 (0.37.1.79) | 0.76 (0.19.2.89) | 0.93 (0.28.3.03) | 0.88 (0.31.2.54) | 0.32 (0.13,0.76) | 0.86 (0.36.2.045) | 0.95 (0.45.2.01) | 1.37 (0.51.3.61) | SGMI + NP | 1.48 (0.75.2.80) | 1.11 (0.58.2.072) | 1.25 (0.31.4.85) |
| 0.88 (0.45.1.82) | 3.33 (1.84,6.10) | 1.74 (0.356.7.77) | 1.11 (0.52.2.43) | 1.063 (0.27.3.95) | 1.29 (0.41.4.13) | 1.23 (0.44.3.36) | 0.44 (0.19.1.013) | 1.19 (0.51.2.74) | 1.32 (0.65.2.68) | 1.91 (0.73.4.84) | 1.38 (0.58.3.36) | SMI + NP | 0.75 (0.43.1.31) | 0.6 (0.22.3.15) |
| 0.91 (0.51.1.59) | 3.38 (2.20,5.28) | 1.77 (0.37.7.45) | 1.14 (0.60.2.17) | 1.075 (0.29.3.77) | 1.32 (0.45.3.83) | 1.26 (0.49.3.14) | 0.45 (0.21.0.92) | 1.22 (0.58.2.48) | 1.34 (0.75.2.39) | 1.94 (0.82.4.61) | 1.41 (0.65.3.086) | 1.019 (0.48.2.14) | SQFZI + NP | 1.13 (0.29.4.29) |
| 1.53 (0.418.6.43) | 5.73 (1.63,23.26) | 3.023 (0.45.20.71) | 1.92 (0.50.8.42) | 1.83 (0.31.11) | 2.23 (0.44.12.45) | 2.10 (0.47.10.54) | 0.76 (0.19.3.34) | 2.064 (0.50.9.33) | 2.26 (0.60.9.56) | 3.26 (0.78.16.42) | 2.39 (0.60.11.06) | 1.74 (0.42.7.98) | 1.69 (0.44.7.34) | XAPI + NP |
Note: The differences between the compared groups were deemed as significant when the 95% CI of the OR did not contain 1.00, which is marked as bold font. ADI, Aidi injection; AI, Astragalus injection; CSI, Chansu injection; CKSI, Compound kushen injection; DLSI, Delisheng injection; HCSI, Huachansu injection; JOEI, Javanica oil emulsion injection; KAI, Kangai injection; KLTI, Kanglaite injection; NP, vinorelbine plus cisplatin; SFI, Shenfu injection; SMI, Shenma injection; SQFZI, Shenqifuzheng injection; SGMI, Shengmai injection; XAPI, Xiaoaiping injection.